Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
RGS22 inhibits pancreatic adenocarcinoma cell migration through the G12/13 α subunit/F-actin pathway
Yanqiu Hu1, Jun Xing2, Ling Chen3
1Reproductive Medicine Center, Subei People's Hospital, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China.
Abstract:
Pancreatic cancer is characterized by the potential for local invasion, allowing it to spread during the early developmental stages of the disease. Regulator of G protein signaling 22 (RGS22) localizes to the cytoplasm in pancreatic adenocarcinoma tissue. We overexpressed RGS22 in the human pancreatic cancer cell line BXPC-3. Cells that overexpressed RGS22 had much lower wound-healing rates and greatly reduced migration compared to the control cells. Conversely, cells in which RGS22 expression had been downregulated had higher wound-healing rates and migration than the control cells. These results confirmed that RGS22 expression suppresses pancreatic adenocarcinoma cell migration. Pull-down and coimmunoprecipitation assays revealed that RGS22 had specific interactions with the heterotrimeric G protein G12 α subunit (GNA12) and GNA13 in the cells. We also demonstrated that in the presence of higher RGS22 expression, the cell deformation and F-actin formation caused by lysophosphatidic acid treatment, is delayed. Constitutively active Gα subunits did not accelerate GTP hydrolysis to GDP. We did not investigate the function of RGS22 as a negative regulator of heterotrimeric G12/13 protein signaling. Our data demonstrate that RGS22 acts as a tumor suppressor, repressing human pancreatic adenocarcinoma cell migration by coupling to GNA12/13, which in turn leads to inhibition of stress fiber formation.
Insights
Regulator of G protein signaling 22 (RGS22) suppresses pancreatic cancer cell migration by inhibiting stress fiber formation. This tumor suppressor function involves coupling to GNA12/13 proteins, impacting cell movement and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Pancreatic cancer exhibits early local invasion and metastasis.
- Regulator of G protein signaling 22 (RGS22) is found in the cytoplasm of pancreatic adenocarcinoma cells.
Purpose of the Study:
- To investigate the role of RGS22 in regulating pancreatic cancer cell migration.
- To elucidate the molecular mechanisms by which RGS22 affects cell motility.
Main Methods:
- Overexpression and downregulation of RGS22 in human pancreatic cancer cell lines (BXPC-3).
- Wound-healing assays and cell migration assays.
- Pull-down assays and coimmunoprecipitation to identify protein interactions.
- Assessment of cell deformation and F-actin formation in response to lysophosphatidic acid.
Main Results:
- RGS22 overexpression reduced wound-healing rates and cell migration.
- RGS22 downregulation increased wound-healing rates and cell migration.
- RGS22 specifically interacts with GNA12 and GNA13.
- RGS22 delays lysophosphatidic acid-induced cell deformation and F-actin formation.
Conclusions:
- RGS22 acts as a tumor suppressor in pancreatic adenocarcinoma.
- RGS22 inhibits pancreatic cancer cell migration by interacting with GNA12/13.
- RGS22's mechanism involves the inhibition of stress fiber formation.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GPCRs Regulate Adenylyl Cylase Activity
Cancer Cell Migration through Invadopodia
Activation and Inactivation of G Proteins
The Ras Gene
Ras is a...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...

